Try our Advanced Search for more refined results
August 16, 2010
Promote Innovation LLC v. Watson Pharma, Inc. et al
Case Number:
2:10-cv-00300
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 02, 2011
Watson Settles Androderm False Marking Suit
Watson Pharmaceuticals Inc. has agreed to stop using packaging for its Androderm testosterone deficiency treatment allegedly labeled with expired patents in order to settle a false marking suit accusing the company of blocking innovation in the industry.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login